A Study to Investigate BAY2402234, a Dihydroorotate Dehydrogenase (DHODH) Inhibitor, in Myeloid Malignancies
Clinical trial NCT03404726 · TERMINATED
Trial details
- NCT number
- NCT03404726
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-29
- Primary completion
- 2021-01-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.